戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n remission, and one with toxoplasmosis plus lymphomatoid granulomatosis).
2 n of central nervous system involvement from lymphomatoid granulomatosis.
3 monary T- or NK-cell angiocentric lymphomas (lymphomatoid granulomatosis), 12/19 T-cell anaplastic la
4 ma closely mimics the full spectrum of human lymphomatoid granulomatosis, an EBV-associated malignanc
5 lfa-2b is efficacious for treating low-grade lymphomatoid granulomatosis and hence reducing progressi
6 crosis and vascular damage from EBV-positive lymphomatoid granulomatosis and nasal or nasal-type T/na
7 mally elevated in patients with EBV-positive lymphomatoid granulomatosis and nasal or nasal-type T/NK
8 er with untreated, or relapsed or refractory lymphomatoid granulomatosis at the National Cancer Insti
9                                              Lymphomatoid granulomatosis has a high rate of central n
10                                              Lymphomatoid granulomatosis is a rare Epstein-Barr virus
11 n this study, we hypothesised that low-grade lymphomatoid granulomatosis is immune-dependent and high
12 lomatosis is immune-dependent and high-grade lymphomatoid granulomatosis is immune-independent.
13  Epstein-Barr virus (EBV) infection, such as lymphomatoid granulomatosis (LG) or post-transplant lymp
14                                              Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr
15                                              Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr
16                                              Lymphomatoid granulomatosis (LyG) is an angiodestructive
17 de disease, whereas patients with high-grade lymphomatoid granulomatosis showed expected responses to
18 , and he had a biopsy-confirmed diagnosis of lymphomatoid granulomatosis that evolved into fatal B-ce
19 y-one patients with pathologically confirmed lymphomatoid granulomatosis were enrolled in a natural h